Retinal concentration and protective effect against retinal ischemia of nilvadipine in rats

European Journal of Ophthalmology

Volumn 18, Issue 1, 2008, Pages 87-93

  Uemura, A ^a   Mizota, Atsushi ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Apoptosis; Calcium channel blocker; Ischemia reperfusion; Nilvadipine; Rat; Retina

Indexed keywords

FAT; NIFEDIPINE; NILVADIPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD RETINA BARRIER; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG PENETRATION; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RETINA; RETINA CELL; RETINA DISEASE; RETINA GANGLION CELL; RETINA ISCHEMIA; THICKNESS;

EID: 41149138263     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800115     Document Type: Article

References (21)

1. Abe K, Kogure K, Watanabe T. Prevention of ischemic and postischemic brain edema by a novel calcium antagonist (PN200-110). J Cereb Blood Flow Metab 1988; 8: 436-9.
2. Hadani M, Young W, Flamm ES. Nicardipine reduces calcium accumulation and electrolyte derangements in regional cerebral ischemia in rats. Stroke 1988; 19: 1125-32.
3. Kuwaki T, Satoh H, Ono T, Shibuyama F, Yamashita T, Nishimura T. Nilvadipine attenuates ischemic degradation of gerbil brain cytoskeletal proteins. Stroke 1989; 20: 78-83.
4. Takakura S, Susumu T, Satoh H, Mori J, Shiino A, Handa J. Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats. Jpn J Pharmacol 1991; 56: 547-50.
5. Goldberg I. Therapeutic possibilities for calcium channel blockers in glaucoma. In: Osborne NN, Chader GJ, eds. Progress in retinal and eye research. Oxford: Elsevier Science, 1994; 13: 593-604.
6. Osborne NN, Wood JP, Cupido A, Melena J, Chidlow G. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Invest Ophthalmol Vis Sci 2002; 43: 1456-64.
7. Ohtsuka M, Ono T, Hiroi J, Esumi K, Kikuchi H, Kumada S. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists. J Cardiovasc Pharmacol 1983; 5: 1074-82.
8. Takakura S, Sogabe K, Satoh H, et al. Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride. Neurosci Lett 1992; 141: 199-202.
9. Yamazaki H, Ohguro H, Maeda T, et al. Preservation of retinal morphology and functions in royal collage surgeons rat by nilvadipine, a Ca(2+) antagonist. Invest Ophthalmol Vis Sci 2002; 43: 919-26.
10. Carnerup MA, Åkesson B, Jönsson BAG. Determination of 5-hydroxy-N-methyl-2-pyrrolidone and 2-hydroxy-N-methylsuccinimide in human plasma and urine using liquid chromatography-electrospray tandem mass spectrometry. J Chromatography B 2001; 761: 107-13.
11. Yasuda T, Tanaka M, Iba K. Quantitative determination of amlodipine in serum by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. J Mass Spectrom 1996; 31: 879-84.
12. Yokoyama A, Oshitari T, Negishi H, Dezawa M, Mizota A, Adachi-Usami E. Protection of retinal ganglion cells from ischemia-reperfusion injury by electrically applied Hsp27. Invest Ophthalmol Vis Sci 2001; 42: 3283-6.
13. Lam TT, Abler AS, Kwong JM, Tso MO. N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci 1999; 40: 2391-7.
14. Taniai M, Sato E, Mizota A, Adachi-Usami E. Protective action of nipradilol against ischemia-induced retinal damage in rats. Ophthalmic Res 2002; 34: 331-7.
15. Wood JP, DeSantis L, Chao HM, Osborne NN. Topically applied betaxolol attenuates ischemia-induced effects to the rat retina and stimulates BDNF mRNA. Exp Eye Res 2001; 72: 79-86.
16. Araie M, Muta K. Effect of long-term topical betaxolol on tissue circulation in the iris and optic nerve head. Exp Eye Res 1997; 64: 167-72.
17. Grozdanic SD, Sakaguchi DS, Kwon YH, Kardon RH, Sonea IM. Functional characterization of retina and optic nerve after acute ocular ischemia in rats. Invest Ophthalmol Vis Sci 2003; 44: 2597-605.
18. Toriu N, Sasaoka M, Shimazawa M, Sugiyama T, Hara H. Effects of Lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1- distributed circulation in the optic nerve head of rabbits. J Ocul Pharmacol Ther 2001; 17: 131-49.
19. Otori Y, Kusaka S, Kawasaki A, Morimura H, Miki A, Tano Y. Protective effect of nilvadipine against glutamate neurotoxicity in purified retinal ganglion cells. Brain Res 2003; 961: 213-9.
20. Tokuma Y, Fujiwara T, Noguchi H. Absorption, distribution and excretion of nilvadipine, a new calcium channel antagonist, in rats and dogs. Xenobiotica 1987; 17: 1341-9.
21. Inouye M, Mio K, Sumino K. Nilvadipine protected low-density lipoprotein cholesterol from in vivo oxidation in hypertensive patients with risk factors for atherosclerosis. Eur J Clin Pharmacol 2000; 56: 35-51.